30 results
Therapeutic Indications for the Anticonvulsant Agents

#Anticonvulsant #Antiseizure #Medications #Pharmacology #Table #Neurology #Epilepsy #Management
#Medications #Pharmacology ... #Table #Neurology ... #Epilepsy #Management
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... #Medications #management ... #pharmacology # ... Table
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Management #Therapy ... #Table #Overview
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... Thiazide #CHF #Cardiology ... #Management
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
#Medications #Table ... #Pharmacology # ... Management #Neurology
Status Epilepticus Pharmacotherapy Guide

 • Phenytoin and Fosphenytoin
 • Valproate Sodium
 • Levetiracetam
 • Lacosamide
 •
#Epilepticus #Pharmacology ... #neurology #management
Acute Treatment of Migraine
Mild Attacks: NSAIDs, Simple Analgesics
Moderate/Severe Attacks: Triptans, Ditans, Gepants, Ergots
Non-pharmacologic Treatment: Neuromodulation, Rest,
Gepants, Ergots Non-pharmacologic ... acute #treatment #management ... #neurology
Immunosuppression in Transplantation
Induction (I):
 - Basiliximab (Simulect)
 - Alemtuzumab (Campath)
 - Rituximab
 - Anti-Thymocyte Globulin (ATG)
Induction
#Medications #Pharmacology ... #Table #Drugs # ... #Maintenance #Management ... #Nephrology #Renal
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... #medications #table ... #decisionaid #cardiology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology